Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Insiders Show Strong Belief in Charles Colvard Ltd

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
TMUS stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Insiders within Charles & Colvard, Ltd. have recently been increasing their holdings, showing strong belief in the company’s potential. Director Ollin B Sykes bought 44,940 shares at an average price of $0.38, totaling approximately $17,287. President and CEO Don O’Connell also acquired 30,000 shares at an average price of $0.34, costing around $10,164. These insider trades indicate optimism for the future of Charles & Colvard, even after the company reported a quarterly loss of 9 cents per share on February 13th.

CTHR Stock Price Jumps 3.38% on March 4, 2024: Is This the Start of a Trend?

On March 4, 2024, CTHR stock experienced a positive price momentum, with shares increasing by $0.01 since the previous market close. This represents a 3.38% rise in the stock price, opening at $0.36, which was $0.01 higher than its previous close.

Investors should take note of the price movement on March 4 and consider whether this short-term increase is indicative of a larger trend or simply a temporary fluctuation. It is important to conduct thorough research and analysis before making any investment decisions regarding CTHR or any other stock.

CTHR Stock Performance Under Scrutiny: Revenue Decline and Net Loss Reported

On March 4, 2024, the stock performance of CTHR, or Charles & Colvard, was under scrutiny as the company released its financial data for the past year and the most recent quarter. According to CNN Money, CTHR reported a total revenue of $29.95 million for the past year, which was a decrease of 30.5% compared to the previous year. The total revenue for the most recent quarter was $7.91 million, showing a significant increase of 59.61% since the last quarter.

In terms of net income, CTHR reported a net loss of $19.58 million for the past year, which was a substantial decrease of 924.83% compared to the previous year. The net loss for the most recent quarter was $2.87 million, representing a decrease of 12.86% since the last quarter.

Earnings per share (EPS) for CTHR were also negatively impacted, with the company reporting an EPS of -$0.64 for the past year, a decrease of 950.4% compared to the previous year. The EPS for the most recent quarter was -$0.09, showing a decrease of 13.19% since the last quarter.

Overall, the financial data released by CTHR on March 4, 2024, painted a mixed picture of the company’s performance. Investors and analysts will be closely monitoring CTHR’s future financial reports to see if the company can turn around its negative performance and improve its bottom line.

Tags: CTHR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Charts for stock trading

Analyst Evaluations and Price Targets for Analog Devices NASDAQ ADI

Entertainment Trading online

Netflixs Triumph A ForwardThinking Approach to Streaming Success

Entertainment Markets and money

Disneys Strategic Initiatives for Success and Sustainability

Recommended

Gilead Sciences Stock

Gilead Sciences: Can a Twice-Yearly HIV Injection Drive Its Next Growth Phase?

3 weeks ago
TGT stock news

Federated Hermes Inc. Reduces Position in KBR, Inc. Amid Positive Earnings Report

2 years ago
Beam Therapeutics Inc Stock

Can Beam Therapeutics Stock Recover From Its Downturn?

4 weeks ago
CTVA stock news

Analyst Reiterates Neutral Rating on OneSpan with Increased Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Emerges as Gene Editing Front-Runner with Accelerated Trial Progress

Occidental Petroleum’s Strategic Pivot to Carbon Management

Applied Materials Secures Major Financing Amid Semiconductor Sector Rally

Amphenol Shares Target New Highs on Strong Industrial Demand

Navigating the Crosscurrents: The iShares Global Clean Energy ETF’s Complex Landscape

Airbus Faces Critical Test Amid Expansion and Labor Tensions

Trending

Porsche Holding Stock
Analysis

Porsche Holding Faces Perfect Storm as Strategic Shifts and Market Pressures Mount

by Robert Sasse
September 22, 2025
0

Porsche Holding finds itself navigating exceptionally turbulent waters, caught in a confluence of adverse events stemming from...

Replimune Stock

Replimune Shares Plummet Amid Regulatory Crisis and Mounting Litigation

September 22, 2025
Texas Instruments Stock

Dividend Growth and Geopolitical Strain: The Texas Instruments Dilemma

September 22, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Emerges as Gene Editing Front-Runner with Accelerated Trial Progress

September 22, 2025
Occidental Petroleum Stock

Occidental Petroleum’s Strategic Pivot to Carbon Management

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Porsche Holding Faces Perfect Storm as Strategic Shifts and Market Pressures Mount
  • Replimune Shares Plummet Amid Regulatory Crisis and Mounting Litigation
  • Dividend Growth and Geopolitical Strain: The Texas Instruments Dilemma

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com